Lataa...
β-arrestin1 at the cross-road of endothelin-1 signaling in cancer
The advent of targeted therapeutics in human cancer has begun to find novel druggable targets and, in this context, the endothelin-1 receptor (ET-1R), namely ET(A) receptor (ET(A)R) and ET(B) receptor, among the GPCR family represents a class of highly druggable molecules in cancer. ET-1R are aberra...
Tallennettuna:
| Julkaisussa: | J Exp Clin Cancer Res |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4966762/ https://ncbi.nlm.nih.gov/pubmed/27473335 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-016-0401-4 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|